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Theophylline and Melanocyte-Stimulating Hormone Effects on 
Gamma-Glutamyl Transpeptidase and DOPA Reactions in Cultured 
Melanoma Cells 
FUNAN Ru, M.D. 
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Gamma-glutamyl transpeptidase (GGT), an enzyme of 
the y-glutamyl cycle, was demonstrated in 3 of 6 cell 
lines derived from a single BI6 murine melanoma. Its 
activity in these cells varied a great deal, appeared to be 
correlated with the developmental cycle of the cells, and 
was greatest in young, actively melanogenic cells. Gen-
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an enzyme specific for melanin synthesis. The levels of 
both enzymes tended to decline with prolonged in vitro 
cultivation, but could be readily renewed after one ani-
mal passage. The 3 cell lines that were GGT-negative 
were nonpigmented and DOPA-negative; so was a non-
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melanogenic and nonmelanocytic rhesus cell line. Mela-
nocyte-stimulating hormone (MSH) and theophylline 
both enhanced pigmentation in murine melanoma cells. 
The mechanisms of their action apparently differed. We 
found that theophylline increased both DOP A- and GGT-
reactive cells, whereas MSH only increased DOP A-re-
active cells. All 3 GGT-positive lines were tumorigenic, 
and 2 GGT-negative lines were not tumorigenic. Our 
observations suggest that GGT plays a role in the mela-
nin biosynthetic pathway and that its activity is greater 
in melanoma cells that are tumorigenic. 
Gamma-glutamyl transpeptidase (GGT), one of the enzymes 
of the y-glutamyl cycle, has been found to be active in cells 
during early differentiation and malignant transformation. Its 
function is believed to involve transmembrane amino acid trans-
port [1] and support of protein synthesis. 
Human and rat lymphocytes undergoing blast transformation 
increase their transpeptidase content [2]. It has been suggested 
that GGT is an important surface marker enzyme reflecting 
differences between normal and neoplastic cells [2]. However, 
Takahashi, Seifter, and Ritas [3] compared GGT activities in 
human diploid fibroblasts and other mammalian cells in culture 
and found that transformed cells (VA, HeLa S3, and eHO) had 
the least activity, followed in increasing order by fibroblasts, 
human and bovine epithelial cells, and monkey kidney epithe-
lial cells. Gamma-glutamyl transpeptidase activity also has 
been reported to increase in aging fibroblasts (WI38) as they 
approached "phase-out" [4]. Takahashi, Seifter, and Ritas 
thought that the large increase in cell size at this stage could 
lead to changes in the membranes where the enzyme is located. 
Growth in soft agar and cytochemical assay of GGT activity 
were suggested as reliable markers for transformation of adult 
rat liver epithelial cell cultures [5,6]. We have found that not 
only melanoma cells are GGT-positive; normal melanocytes at 
certain stages of development also have GGT activities [7,8]. 
The latter activity appears to be related to the active growth 
phase of the cells. Generally, we have found that malignant 
melanoma cells have grenter activity than normal and nontu-
morigenic melanocytes. Thus, a correlation between tumori-
genicity and GGT activity appears to exist. 
The GGT activity in cultured melanoma cells varies a great 
deal. It is great in melanocytes during their melanogenic stage, 
but absent from cells not engaging in melanin synthesis [7,8]. 
Its absence from nonmelanogenic melanocytes and high level 
in melanin-synthesizing cells suggest a relationship between 
this enzyme and melanin production. Melanocyte-stimulating 
hormone (MSH) and theophylline have been shown to enhance 
pigmentation in pigment cells [9-12]. In the study described 
here, we investigated the effects of theophylline and MSH on 
GGT activity in cultured murine melanoma cells. 
MATERIALS AND METHODS 
Cell Lines 
Established murine B16 melanoma cell lines [13-15], designated as 
HFH1B-(15) -F, HFH-(15)-C, HFHIB-(94), NP133, NP135, . and P51 
[14-15], as well as primary monolayer cell cultures of mouse tumors 
resulting from injection of the above-mentioned established celllines,* 
• All melanoma celllines-HFHIB-(15)-C, HFHIB-(15)-F, HFHIB-
(94), P51, NP133, and NPl35-were examined for their tumorigenicity 
by intramuscular injection of 106 cells suspended in Hanks' balanced 
salt solu tion into both hind legs of 6-week-old C57BL/6 mice. Tumors 
usually developed in 3 to 4 weeks. When they were 1 cm in diameter, 
the tumors were excised and used to set up primary cell cultures. 
Line HFHIB-(15)-CT cells; theophylline 1.5 roM; the combined 
DOPA-GGT histochemical method (x 160). A mixture of DOPA-po~i­
tive, GGT-positive, and nonreactive cells. Note some DOPA-positive 
cells have both juxtanuclear and peripheral reactions (type B). Some 
(the very dark cells) have only a peripheral reaction (type C). Most of 
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designated as HFHIB-(15)-FT, HFH1B-(l5)-CT, HFH1B-(94) -T, 
NPI33-T, and P51-T, were used. Because NP135 is not tumorigenic, 
only the original cell line was used. All lines were established at different 
times from cell cultures (HFH1B) originated in 1963 from a B16 mela-
noma carried in C57BL/6 mice in my laboratory [13]. The primary 
cultures were carried in vitro for 22 passages, and frozen in 1963 and 
thawed in 1975. All 3 HFHIB sublines-HFH1B-(15)-C, HFHIB-(15)-F 
and HFH1B-(94)-were derived from these frozen-thawed cells. P51 
line was established from pigmented tumors after injections of HFH1B 
cells into C57BL/6 mice in 1964 [15]. NP lines were derived from a 
nonpigmented tumor established in 1964 by both in vitro and in vivo 
selection of nonpigmented HFHIB cells. NP133 cells underwent passage 
133 times in mice before they were put into cultures in 1972. They 
underwent subculture 16 times and one freezing-thawing between 1972 
and 1973; then they underwent passage 35 times in vivo until 1975, 
when primary cultures were made from one of these nonpigmented 
tumors. NP135 cells, unlike NP133 cells, had 2 additional passages in 
mice before they were put into culture in 1972. Subsequent passage 
histories of all lines used in this study are summarized in Table 1. Line 
(15)-C is more pigmented than line (94), which has only a few pigmented 
cells. Line P51 has even less pigmented cells than line (94) . Line (l5)-F 
is the most pigmented. Both NP Hnes completely lack pigment. 
All melanoma lines grew well in culture. Morphologically, NP cells, 
particularly NP135 cells, were different from pigmented cells, i.e., they 
were larger and flatter and did not pile up as much. In addition, RF / 
6A, a cell line derived from the eyes of a 64-day-old rhesus fetus, was 
included as a non tumorigenic and nonmelanogenic control [16]. 
Histochemical Reactions 
1. Gamma·glutamyl transpeptidase reaction: For h istochemical 
demonstration of GGT activity, monolayer cell cultures were fixed with 
10% buffered neutral formalin (BNF) (pH 7.0) for 10 min and were 
assayed with a technique modified by Rutenburg et al [17). Two basic 
stock solutions were prepared. The first contained 5 mg of y-glutamyl-
4-methoxynaphthylamide (Vega-Fox Chemicals, Tucson, Arizona), 0.1 
ml of dimethylsulfoxide, 0.1 ml of 1 N NaOH, and 1.B rn1 of distilled 
water; the second contained 20 mg of glycylglycine (Sigma) in 10 rn1 of 
0.1 M tris(hydroxymethyl)aminomethane (pH 7.4) and 2B rn1 of 0.B5% 
NaC!. Solutions 1 (2 m\) and 2 (3B m!) were combined, 20 mg of fast 
blue BBN (Sigma) were added, and the resulting medium was imme-
diately filtered and used. The fixed cells were placed in this solution for 
1 hr at 37°C. After this incubation period, they were rinsed serially in 
0.B5% NaCl, 0.1 M CuSO", 0.B5% NaCl, and distilled water and then 
were mounted in glycerol-gelatin. 
2. DOPA reaction: For histochemical demonstration of tyrosinase 
(DOPA) activity, we adapted the DOPA reaction procedure described 
by Laidlaw and Blackberg [IB] to cultured monolayer cells. Briefly, the 
cells were fixed in 10% BNF for 10 min, rinsed twice with 0.055 M 
phosphate buffer, and incubated in 0.1% L-fl-3,4-dihydroxyphenylala-
nine (dopa) in phosphate buffer at 37°C for 4 hr. Then the cells were 
rinsed twice with phosphate buffer, rinsed with distilled water, and 
mounted with glycerol-gelatin. 
3. Combined DOPA and GGT reaction: Monolayer cell cultw'es 
were fixed with 10% BNF for 10 min and were incubated in a 0.1% dopa 
solution for 4 hr (as described for the regular DOPA procedure). At the 
end of 4 hr, the cells were briefly rinsed 2 times with physiological 
saline; and then were incubated in the GGT substrate for 1 hr at 37°C 
(as described for GGT procedure above). 
4. Other histochemical reactions: The following combinations were 
also used: GGT substrate plus cysteine; GGT substrate plus glutathione; 
dopa plus cysteine; and dopa plus glutathione. 
For the above, 40 mg of L-cysteine/l00 ml or 30 mg of glutathione/ 
100 rn1 (25 mM) were added to the GGT or DOPA substrate and 
incubated as described for regular GGT or DOPA procedure. In addi-
tion, cysteine or glutathione was added to the dopa in the first part of 
the combined DOPA and GGT procedure. The procedure otherwise 
was the same as the regular combined substrate procedure . 
All slides were examined and compared for the number of pigmented 
cells, the degree of pigmentation, the number of GGT- or DOPA-
positive cells, and the intensity of the reaction. In addition, the amounts 
the GGT-reactive cells also show a positive DOPA reaction (type A or 
B). Not all GGT-positive cells react to the same degree. The strongly 
positive cells are bright orange-red, the questionably reactive or non-
reactive cells have only a slight tint of brownish-orange, and the weakly 
and moderately reactive cells are intermediate in color. 
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of growth and the shapes and sizes of the cells in each condition were 
compared. 
Theophylline and Melanocyte-Stimulating Hormone Treatment 
Cells grown on coverglasses or in culture dishes were treated 2 or 3 
days after they had been seeded and had grown into large aggregates 
or had become semiconfluent. For treatments with theophylline (1, 3 
dimethylxanthine, Sigma) we used 3 dosages ranging from 0.125, 0.5 to 
1.5 mM for 3 time periods of 24, 48, and 72 hr. With MSH (a-MSH 
[BA33761] was generously supplied by Ciba Pharmaceutical) we used 
a fixed time-dosage schedule of 0.02 J.Lg/ ml for 48 hr. Afterwards the 
cultures were fixed and prepared for microscopic examinations as 
described above. 
HFH18-(15}-F, HFH18-(15}-C, and HFHIB-(94}-certain per-
centages of cells showed a GGT reaction. But the number of 
positive cells and the degree of reactivity varied a great deal 
among the lines and among cells in a given culture. Reactivity 
varied from negative or weakly positive (faint brown-orange 
tint) to strongly positive (bright orange-red). The variation 
OCCUlTed in both pigmented and nonpigmented cell populations. 
Generally, GGT activity was more prevalent in small ovoid cells 
than in lal"ge cells; it was absent from dal"kly pigmented cells, 
but frequently present in lightly pigmented small cells (Figure). 
RESULTS 
Table II summarizes the DOPA and GGT reactions of 6 
melanoma cell lines and one rhesus cell line incubated in 
different substrates. 
In general, both DOPA and GGT reactions were demon-
strated in descending order in the pigmented melanoma cells, 
i.e ., in HFH1B-(15}-F, HFH1B-(15}-C, and HFH1B-(94} cells. A 
small number of P51 and NP133 cells had orange-red GGT-
positive granules sparsely distributed in the cytoplasm. The 
NP135 and RF / 6A cells had none. All tumors-from injec-
tions of HFHIB-(15}-F, HFHIB-(15}-C, HFHIB-(94}, P51, and 
NP133-showed more striking GGT reactions (i.e., more reac-
tive cells and stronger reactions) than the respective original 
cell lines that produced the tumors; all tumors from injections 
of HFHIB cells were darkly pigmented, more so than the 
original cell lines. For example, both HFHIB-(15} -C and 
HFH1B-(94} cell lines (especially the latter) had only small 
numbers of pigmented cells. When cell suspensions were cen-
trifuged, the pellet formed from HFHIB-(94} was grayish rather 
than black as in the case of HFH18-(15}-F. The HFH18-(15}-C 
was darker than the HFHIB-(94}, but less so than the HFH18-
(15}-F. All tumors, however, from these 3 cell lines were black 
(Table I). Cells in primary cultures made from HFH18 tumors 
[HFH18-(15}-FT, HFHIB-(15}-CT, HFH18-(94}-T] were more 
pigmented, and were more DOPA- and GGT-positive than their 
respective cell lines. Therefore, a passage in vivo increased both 
pigmentation and GGT activity. 
Similarly, all 3 melanogenic melanoma cell lines had cells 
showing a positive DOPA reaction. White, Hanson, and Hu [9] 
have described 3 types of positive L-DOPA reaction observed 
by light microscopy. Type A cells display a distinctive reticular 
pattern of tyrosinase activity in a juxtanuclear position; the 
more peripheral granular pattern characteristic of pigmented 
melanocytes is absent. Type B have peripheral granular-asso-
ciated activity in addition to the juxtanuclear label present in 
type A. Type C cells have the granular label, but lack any 
-
In all the melanogenic melanoma lines we examined-
Cell lines 
HFHI8-(15) -F 
HFH18-(15)-C 
HFH18-(94) 
P51 
NP133 
NPJ35 
Cell line 
HFH18-(15}-F 
HFHI8-(15)-C 
HFH18-(94) 
P51 
NP133 
NP135 
RF/6A 
TABLE I. Passage history of melanoma cell lines used for mouse injections 
History 
62 in vitro passages with 3 freezings/thawings between 1975 and the time ·of injection 
(3/26/80) 
79 passages with 2 freezings/thawings between 1975 and the time of injection (5/ 7/80); 
in. vitro continuously since 1979 
160 in. vitro passages since 1975 with 2 fTeezings/ thawings between J978 and 1979; 
injection on 3/26/80 
51 passages in vivo between 1964 and 1968; 631 in vitro. passages since 1968 with 1 
freezing/ thawing between J 968 and the time of injection (7/28/ 80) 
35 passages in vivo between 1973 and 1975; 2 in. vitro passages and 1 freezing / thawing 
between 1975 and the time of injection (4/9/80) 
42 in vitro passages with 3 freezings/thawings between 1972 and the time of iniection 
(4 /9/80) . 
Tumorigenicity 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
Tumor color 
Black 
Black 
Black 
Grayish-blae!, 
Nonpigmented 
Not applicable 
TABLE II. Gamma-glutamyl transpeptidase and DOPA reactions in different celllin.es with various subs/rates 
Dopa Dopa + cysteine Dopa + glutathione 
+++ ± or + ± or + 
++ ± ± 
+ ± or - ± or-
± ND ND 
ND ND 
ND ND 
ND ND 
GGT 
+++ 
++ 
+ 
± or + 
± or + 
GGT + cyst.eine 
+++ 
++ 
+ 
ND 
ND 
ND 
ND 
GGT + glutathione 
ND 
ND 
ND 
ND 
Abbreviations: dopa, L-,B-3,4-dihydroxyphenylalanine; GGT, substrate for gamma-glutamyl transpeptidase; ND, not done. 
Symbols: +++, approximately 25% of the cells are reactive; ++, approximately 15% of the cells a re reactive: +, scattered small aggregates of 
reactive cells, approximately 5% or less; ± or +, a few scattered reactive cells plus some weakly or questionably reactive cells; ±, weakly or 
questionably reactive cells; -, nonreactive cells. 
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discernible juxtanuclear concentration of reaction product. In 
our study, all the melanogenic lines had cells showing these 3 
types of DOPA reaction. The reactions, however, varied from 
negative to strongly positive. The 2 NP lines did not react at 
all. 
In culture, except a few rare pigmented cells, P51 cells were 
predominantly not pigmented and DOPA-negative. Injections 
of P51 cells into mice produced tumors that were dark, but not 
jet black; by contrast injections of all three HFH18 cell lines 
produced jet black tumors. In spite of the great variations, the 
differences between cell lines and changes in cells incubated in 
different substrates are consistent and reproducible. The data 
summarized in Table II are the results of experiments repeated 
at least 3, and sometimes as many as 10, times. The combined 
substrate histochemical method made it possible to demon-
strate both DOPA and GGT reactions in the same cells. With 
this technique we found many of the lightly pigmented small 
ovoid or bipolar cells were both DOP A- and GGT -reactive. The 
HFHI8-(15) cells-after their incubation in dopa reagent-
could still react with the GGT substrate (Figure). When these 
cells were incubated in a solution of dopa and cysteine or dopa 
and glutathione, they showed some decrease in DOPA reactiv-
ity; but when they were subsequently incubated in the GGT 
substrate, the GGT reaction appeared to be enhanced. The 
difference was consistent but not dramatic. When glutathione 
was added to the GGT substrate, it abolished the reaction. The 
addition of cysteine did not change the reactivity of the cells. 
Both MSH and theophylline (0,5 to 1.5 mM) moderately 
inhibited cell growth. Theophylline was more inhibitory than 
MSH. In addition, both altered the shapes of the cells. The 
HFH18 cells were predominantly small and ovoid, with short, 
stubby processes. Cells incubated in medium containing MSH 
became more spindle-shaped and had tapering dendrites. Theo-
phylline treatment also changed cells morphologically. At a 
concentration of 0.5 to 1.5 mM, the cells became more dendritic, 
but not as spindle-shaped as the MSH cells, and their processes 
tended to come off the small cell bodies more abruptly. This 
effect was dose-dependent; at 0.125 mM theophylline did not 
significantly alter the ceJ!s morphologically. Its effect on growth 
inhibition was also minimal. Cells under the influence of low 
dosages resembled MSH-treated cells, i.e., spindle-shaped cells 
with tapering dendrites. 
Table ill compares the effects of MSH and theophylline on 
the GGT reaction and pigmentation in HFHI8-(15) cells. It 
shows that theophylline increased the percentage of GGT-pos-
itive cells (35% compared to 12% for controls) as well as that of 
pigmented cells (60% versus 36%). On the other hand, MSH did 
not significantly increase the percentage of GGT-positive cells 
(15% compared to 12% for controls) , but did cause an increase 
in pigmented cells (55% versus 36%). All HFH18 lines showed 
significant responses to theophylline treatment; there were 
increases in the numbers of pigmented cells, DOPA-positive 
celis, and GGT -positive cells, as well as increases in the inten-
sities of these reactions (Table III). These phenomena occurred 
both before and after one animal passage. Theophylline had no 
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effect on pigmentation in the NP lines. Line NP133 had a small 
number of cells with cytoplasm containing small orange-red 
granular deposits similar to those seen in GGT-reactive cells. 
Their number somewhat increased after treatment with 1.5 mM 
theophylline in vitro or after one in vivo passage. The reaction 
was mostly weak, i.e., the color was never as bright as the 
orange-red seen in the highly reactive HFH18 cells. Line NP135 
was completely unresponsive. 
The behavior of line P51 resembled that of NP133. Unlike 
NP133, line P51 did have occasional pigmented cells whose 
number increased a little (i.e., from 0-1 to 10-15 cells per 
coverglass) after theophylline treatment. 
The a-MSH also increased the number of pigmented cells 
and degree of pigmentation and DOPA reactivity in all 3 
HFH18 lines, but it had little or no effect on GGT activity. 
DISCUSSION 
Because melanocytes during development, as well as in cul-
ture, change from small ovoid to bipolar, dendritic, and finally 
large epithelioid or platelike cells, possibly the variation in 
GGT reactivity is related to the developmental cycle of the cell. 
Its absence in darkly pigmented large cells suggests that only 
younger, not terminally differentiated, cells exhibit such a re-
action. This idea is supported by autoradiographic evidence 
(unpublished data): thymidine uptake occuned predominantly 
in small ovoid and bipolar cells, but rarely in large epithelioid 
or darkly pigmented cells. Labeling was not observed in strongly 
GGT-reactive small ovoid cells that were classified by their size 
and shape as young melanocytes. This finding seems in conflict 
with the statement that thymidine uptake occurred predomi-
nantly in the smaller younger cells. This contradiction may be 
explained by a generally well-recognized phenomenon, i.e., 
DNA synthesis and mitotic activity are usually curtailed in cells 
actively engaged in synthesizing a differentiation product (mel-
anin in this particular case). Strongly GGT-positive small cells 
mayor may not contain visible melanin, but they are potentially 
melanogenic. In the combined histochemical reactions these 
small cells were often positive for both DOPA and GGT. The 
other small cells that actively took up thymidine were destined 
for division. Their enzyme activities were usually weak or 
nondetectable. The GGT reactions were observed in both pig-
mented and nonpigmented cells in the melanogenic lines 
(HFH18 cells) and iridial stromal melanocytes [7,8], but were 
absent from nonmelanogenic lines (NP133, NP135, and RF /6A) 
and from postnatal choroidal melanocytes and retinal pigment 
epithelium [7,8). The lack of GG T reactivity in nonmelanogenic 
cell lines suggests strongly that GGT plays a role in melanin 
synthesis. Nonmelanotic cells grow well in culture. They do not 
behave differently from their melanogenic counterparts (all 
HFH18 lines) except in their ability to synthesize melanin. 
Prota, Rorsman, and their colleagues [19-21] believe that GGT 
converts glutathionedopa to cysteinyldopa, which is an inter-
mediate in the pheomelanin biosynthetic pathway. The GGT 
reaction in melanogenic melanocytes appears to be enhanced 
by preincubation with dopa together with glutathione or cys-
TABLE III. Effects of theophylline and melanocyte· stimulating hor";'one on pigmentation and distribution of gamma.glutamyl· 
transpeptidase·positiue cells in the HFH18·(I5) line 
Cells 
Percentage of GGT -positive cells" Percentage of pigmented cells" 
0 ± + ++ 0 ± + ++ +++ 
Control 82 6 11 0.7 9 55 32 3.5 0.13 
(1357) (100) (185) (12) (142) (838) (483) (54) (2) 
75 9 15 0 15 28 32 21 2 MSH (1262) (154) (258) (0) (253) (434) (501) (335) (40) 
Theo 50 14 33 2 20 19 38 22 0 (897) (252) (595) (34) (372) (344) (701) (410) (0) 
Abbreviations: GGT, y-glutamyl transpeptidase; MSH, melanocyte-stimulating hormone; Theo, theophylline. 
Symbols: 0, GGT-negative or not pigmented; ±, questionable; +, weakly but defmitely reactive or lightly pigmented· ++ moderately GGT-
positive or moderately pigmented; +++, darkly pigmented. ' , 
"Number in parentheses is the number of ceUs counted. 
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teine, which keeps the reaction from proceeding from dopaqui-
none to eumelanin formation. This phenomenon is in keeping 
with Prota's proposed pheomelanin pathway, in that both cys-
teinyldopa and glutathionedopa in the presence of GGT can 
proceed toward the synthesis of pheomelanin. 
It has been shown that glutathione inhibits the reaction from 
tyrosine or dopa to melanin [22]. Glutathione, but not cysteine, 
competes for the enzyme in the GGT reaction, and so when 
glutathione is added to the incubation substrate for GGT it 
abolishes the reaction [17]. The GGT activity appears to coin-
cide with the growth and eal'ly differentiation of melanocytes; 
it declines with maturation and is finally lost at terminal differ-
entiation [7,B]. The activity of tyrosinase somewhat parallels 
that of GGT; it begins to appear during early development, 
reaches its peak at maturity, and declines when the cells grow 
old. Both enzymes exist in the growth and development phase 
of melanocytes, when the cells are active in melanogenesis. The 
activities of the 2 enzymes, however, are expressed without 
interference from each other. One can perform cytochemical 
assays for DOPA and GGT in succession without altering their 
respective activities. 
San et al have used GGT activity as a cell marker to identify 
neoplastic transformation of liver epithelial cells in culture [6]. 
Similarly, we found that the tumorigenic melanoma cell lines 
HFH1B-(15)-C, HFH1B-(15) -F, and HFHIB-(94) had greater 
GGT activity than the non tumorigenic line NP135. In addition, 
we observed that one in vivo passage in syngeneic hosts in-
creased both the DOPA and the GGT activity in tumors and in 
primary cell cultures made from these tumors. The HFH1B-
(15)-F was more pigmented and more GGT-positive than its 
sister cell lines HFH18-(15)-C and HFH1B-(94), which had 
undergone many more passages in culture (Table 1). Generally, 
the degree of pigmentation and the GGT activity appeared to 
be in reverse proportion to the number of passages. The activity 
of these 2 enzymes decreased as the time in culture increased. 
The NP cell lines were genetically nonmelanogenic owing to 
the lack of tyrosinase; a passage in vivo did not correct this 
defect. The cells remained DOPA-negative. Line NP135 was 
GGT-negative as well as nontumorigenic. Lines NP133 and P51 
were tumorigenic; both were found to have a small number of 
cells containing GGT-reactive orange-red granules in their cy-
toplasm, which tended to increase in amount when the cells 
underwent passage in vivo or were treated with theophylline. 
The tumorigenicity of NP133'cells can be easily explained: they 
were cultured from a nonpigmented tumor and had undergone 
only 2 passages in vitro (Table I). Line P51, however, was 
carried continuously for 634 subcultures and was interrupted 
by only one freezing and thawing in a period of 12 yr. DW'ing 
this interval the number of pigmented cells decreased progres-
sively, and now the line has become practically free of such 
cells. However, these cells did produce dark tumors when 
injected into C57BL/6 mice. 
The growth and pigmentation responses of two melanoma 
cell lines (HFH1B and P /140) to theophylline and MSH have 
been shown by White, Hanson, and Hu [9] to be quite different. 
Theophylline-induced changes in pigmentation do not require 
the participation of higher intracellular cyclic AMP (cAMP) 
levels. This effect is in direct contrast to the effects of a-MSH, 
which are mediated through cAMP. Caffeine and theophylline 
inhibit postreplication repair in ultraviolet-light-ilTadiated cells 
in cultw·e. This inhibition also does not seem to be mediated 
by cAMP, but is probably the result of a dU'ect action of 
theophylline on DNA [23]. The effect of theophylline on GGT 
activity apperu's to resemble that on tyrosinase activity, i.e., 
theophylline stiInulates both. However, MSH does not induce 
a significant increase in GGT -positive celis, although it is effec-
tive, as is theophylline, in enhancing pigmentation in melano-
genic melanoma cell lines. Neither GGT nor tyrosinase activity 
has been demonstrated in the amelanotic melanoma cell line 
(NP135) with or without theophylline or MSH treatment. The 
nonmeianocytic cell line RF / 6A is also not reactive. In theo-
phylline-stimulated melanocytes there is a distinct increase in 
Golgi-related vesicles and cisternae, which are filled with DOPA 
reaction products [9]. The DOPA reaction is always negative in 
the nonmelanogenic cell lines (NP and RF/ 6A). 
Gamma-glutamyl transpeptidase is known to catalyze the 
initial step in the degradative metabolism of glutathione. Hal-
prin and Ohkawru'a [22] have suggested that reduced glutathi-
one helps control pigmentation by inhibiting melanin formation 
from tyrosine and dopa. These investigators have demonstrated 
that glutathione reductase activity and reduced glutathione are 
less in Negro skin than in Caucasian, and hyperpigmentation 
after exposure to ultraviolet light is preceded by a drop in the 
levels of glutathione reductase and reduced glutathione. 
Glutathione reacts with dopaquinone to form glutathione-
dopa, which, through the enzyme GGT, is converted to cystein-
yldopa [19-21]' Cysteinyldopa can also be formed dU'ectly 
thI'ough the combination of dopaquinone and cysteine without 
the intervention of an enzyme. According to Prota's pheomel-
anin biosynthetic pathway, cysteinyJdopa is the principal inter-
mediate that leads to pheomelanin formation [19]. 
Our fmdings that GGT is present only in melanogenic mela-
nocytes and that in vitro theophylline enhances pigmentation 
and GGT activity in melanogenic melanoma cells suggest active 
pruticipation of GGT in the melanin biosynthetic process. 
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ANNOUNCEMENTS 
The joint meeting of the Society for Investigative Dermatology, Inc. 
and the European Society for Dermatological Research will be held at 
the Capitol Hilton Hotel in Washington, D.C. , U.S.A., April 27-May 1, 
1983. 
All abstracts must be submitted to Dr. Kirk Wuepper, Secretary/ 
Treasurer, The Society for Investigative Dermatology, Inc., 14435 S.W. 
Uplands Drive, Lake Oswego, OR 97034 . Abstracts must be received on 
or before December 6, 1981, and postmarked on or before December 1, 
1981. Forms may be obtained from Dr. Herbert Honigsmann, Secretary, 
ESDR, Department of Dermatology, I, University of Vienna, Alser-
strasse 4, A-1080 Vienna, Austria, or Dr. Kirk D . Wuepper. 
The International Symposium on Paediatric Dermatology, Mazara 
del Vallo (Trapani), will be held September 22-25, 1982. It is promoted 
by the Foundation for Research in Dermatology under the auspices of 
the European Society for Dermatological Research, Italian Society of 
Dermatology, Italian Dermatological Association, and the Italian So-
ciety of Paediatrics. President: F. Serri, Professor and Chairman, De-
partment of Dermatology Catholic University, Rome; Scientific Sec-
retariat: G. Fabrizi, S. Gatti, Department of Dermatology, Catholic 
University, 00168 Rome (Tel: 06-33054227/33054211) ; Scientific Orga-
nization Secretariat: E. Shargool, M.El Hachem, Foundation for Re-
search in Dermatology, Largo Gemelli 8, 00168 Rome (Tel: 06-3385451). 
The United Scleroderma Foundation awarded $3,000 to Yasuoki 
Moroi, Carol Peebles, Marvin Fritzler, J. Steigerwald, and Eng Tan 
from the University of Colorado Medical Center for their paper 
"Autoantibody to centromere (kinetochore) in scleroderma sera." (Proc 
Natl Acad Sci 77:1627-1631, 1980.) The United Scleroderma Founda-
tion again plans to award $3,000 for the best research article on 
scleroderma published in 1982. Names of applicants for the award, 
together with supporting data, should be submitted by December 30, 
1982. Results of the research must have been presented at a scientifiC 
medical meeting or published in a recognized medical jourllal. The 
award recipient will be determined by a committee. Address all com-
munications to Denny L. Tuffanelli, M.D., Department of Dermatology, 
University of California School of Medicine, San Francisco, CA 94143. 
The Westwood Pre-Board Slide Seminar will take place September 
10-12, 1982 at the O'Hare/Kennedy Holiday Inn in Rosemont (Chi-
cago), Illinois. For information and registration, contact Frank Brisben 
or Kris Eimiller at Westwood Pharmaceuticals, 468 Dewitt Street, 
Buffalo, NY 14213, or call 716-887-3702. 
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